pemetrexed mylan 1000 mg
mylan ireland limited, Írsko - pemetrexed - 44 - cytostatica
pemetrexed mylan 500 mg
mylan ireland limited, Írsko - pemetrexed - 44 - cytostatica
pemetrexed mylan 100 mg
mylan ireland limited, Írsko - pemetrexed - 44 - cytostatica
kesimpta
novartis ireland ltd - ofatumumab - roztrúsená skleróza, recidivujúce-odosielajúcej - immunosuppressant - kesimpta is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features (see section 5.
ngenla
pfizer europe ma eeig - somatrogon - growth and development - hypofÝzy a hypotalamickÝch hormÓny a ich analÓgy - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.
ebglyss
almirall, s.a. - lebrikizumab - dermatitída, atopická - ostatné dermatologické prípravky - ebglyss is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older with a body weight of at least 40 kg who are candidates for systemic therapy.
prothromplex nf 600 iu
baxalta innovations gmbh, rakúsko - koagulačné faktory ix, ii, vii a x v kombinácii - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
gemcitabín sun 10 mg/ml infúzny roztok
sun pharmaceutical industries europe b.v. , holandsko - gemcitabín - 44 - cytostatica
luna experience
bayer ag - dispergovateľný koncentrát - fluopyram 200 g/l; tebuconazole 200 g/l
vyepti
h. lundbeck a/s - eptinezumab - poruchy migrény - analgetiká - vyepti is indicated for the prophylaxis of migraine in adults who have at least 4 migraine days per month.